COMMUNIQUÉS West-GlobeNewswire

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
07/08/2026
VALENCIA, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it will be [...]
Vireo Growth Announces Asset Based Credit Facility
07/08/2026
Facility enhances financial flexibility and supports continued execution of the Company's disciplined growth strategy MINNEAPOLIS, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” [...]
CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The PSP Trial Platform (PTP), a landmark clinical trial testing multiple drugs simultaneously in the search for effective PSP treatments, has enrolled its first participant. [...]
ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report
07/08/2026
ChemoMetec A/S announces its Annual Report for the financial year 2025/26 on Thursday, 10 September, 2026. Following the announcement ChemoMetec A/S will host a conference call on Friday, 11 September, 2026, at 3:00 p.m [...]
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
07/08/2026
-- Potential proceeds would be received upon full cash exercise of warrants -- ATLANTA, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility [...]
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity [...]
UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The PSP Trial Platform (PTP), a landmark clinical trial testing multiple drugs simultaneously in the search for effective PSP treatments, has enrolled its first participant. [...]
Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years
07/08/2026
MVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virus Approval further strengthens MVA-BN’s position in supporting global [...]
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
07/08/2026
Tokyo, Japan and Cambridge, UK, 7 August 202 6 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter ended 30 June [...]
National Health Sanitary Association Announces United Nations Procurement and Partnership Registration
07/08/2026
Washington State-based public health organization expands international cooperation framework for disease prevention, health education, humanitarian assistance and community health development. WASHINGTON, Aug. 07, 2026 [...]
Better U Expands 2026 Patient Eligibility, Safety and Treatment Access Information for At-Home Ketamine Therapy
07/08/2026
Online eligibility screening, off-label compounded oral ketamine and licensed pharmacy fulfillment explained, with SPRAVATO esketamine offered separately WEST HOLLYWOOD, Calif.,, Aug. 06, 2026 (GLOBE NEWSWIRE) -- [...]
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
07/08/2026
THOUSAND OAKS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Latigo Biotherapeutics, Inc. (“Latigo”), a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines, today announced [...]
BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering
07/08/2026
SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. , (“BlossomHill Therapeutics”), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop [...]
CancerVax Achieves Major Milestone in Activating Human Killer T-Cells Against Cancer
07/08/2026
In-vitro studies confirmed that the Company’s revolutionary therapy successfully disguised liver cancer cells as virally infected cells and activated pre-existing human antiviral Killer T-cells Lehi Utah, Aug. 06, 2026 [...]
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
06/08/2026
Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of enrollment expected in 2027. Bimatoprost-Drug Ring System (BIM-DRS) first-in- [...]
SkinHealth Systems Reports Second Quarter 2026 Financial Results
06/08/2026
LONG BEACH, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
06/08/2026
CONSHOHOCKEN, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
06/08/2026
Clinical, safety and translational data presented at EULAR 2026 reinforced AlloNK ® ’s potential to drive deep B-cell depletion and meaningful clinical activity, with a tolerability profile supportive of outpatient [...]
Caring Brands Provides Intellectual Property Portfolio Update
06/08/2026
Commercial Patent Portfolio Includes Five Issued U.S. Patents Protecting Core Flagship Platforms Targeting $20B+ Combined Global Dermatology & Hair Care Markets Fort Pierce, FL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- [...]

Pages